May 28, 2026 07:05AM
May 5, 2026 04:05PM
Apr 28, 2026 09:05AM
Apr 16, 2026 04:05PM
Mar 28, 2026 10:05AM
Mar 28, 2026 10:05AM
Mar 18, 2026 03:39PM Protagonist Therapeutics (PTGX) PT Raised to $104 at Clear Street
Mar 18, 2026 12:17PM
Mar 18, 2026 10:28AM
Mar 18, 2026 08:05AM
Mar 18, 2026 08:05AM
Mar 2, 2026 06:01AM
Mar 2, 2026 02:00AM
Feb 25, 2026 05:15PM CORRECTION: Protagonist Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Feb 25, 2026 04:05PM
Jan 30, 2026 06:47AM
Jan 5, 2026 07:03AM
Jan 5, 2026 07:00AM
Dec 12, 2025 04:54AM
Dec 8, 2025 02:54AM
Dec 6, 2025 09:30AM Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera
Nov 6, 2025 04:05PM
Oct 7, 2025 11:00PM
Aug 7, 2025 04:18AM
Aug 6, 2025 04:05PM
Jun 1, 2025 08:00AM
Mar 3, 2025 01:28PM
Mar 3, 2025 06:46AM Protagonist Therapeutics (PTGX) and Takeda (TAK) Announce Positive Topline Results from Phase 3 VERIFY Study of Rusfertide in Patients with Polycythemia Vera
Mar 3, 2025 06:45AM
Feb 21, 2025 07:00AM
Jan 6, 2025 04:05PM
Nov 7, 2024 04:05PM
Apr 16, 2024 09:00AM
Jan 31, 2024 04:09PM
Jan 31, 2024 04:05PM Takeda and Protagonist Therapeutics, Inc. Enter into Worldwide License and Collaboration Agreement for Rusfertide, a Late-Stage Rare Hematology Asset
Apr 4, 2023 05:41PM
Mar 15, 2023 04:01PM
Aug 4, 2022 04:05PM
May 4, 2022 04:05PM
Apr 26, 2022 08:54AM
Apr 13, 2022 05:11PM
Apr 12, 2022 09:00AM Alpha Cognition Announces Change of CFO, Grant of Stock Options and Addition to the Board of Directors
Feb 11, 2022 06:01AM
Nov 4, 2021 07:00AM
Nov 3, 2021 04:05PM
Oct 12, 2021 06:10AM
Oct 11, 2021 09:21AM
Oct 11, 2021 07:20AM
Oct 11, 2021 07:01AM Protagonist Therapeutics (PTGX) Announces Removal of FDA Clinical Hold on the Rusfertide Clinical Development Program
Oct 11, 2021 07:00AM

322,088 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All